More information about Medix Biochemica
Experience - Expertise - Excellence
At Medix Biochemica, operational excellence goes beyond manufacturing. Every day, their team around the world works tirelessly to improve their performance. Enhance their efficiency. And execute flawlessly. Every time.
Their innovative approach delivers commercially successful antibodies and antigens with pioneering antibody technology based on in vitro manufacturing under the strictest international quality standards (ISO 9001, ISO 13485, and FDA QSR). The services equip IVD manufacturers with a competitive advantage, helping to increase sales revenue without the need to invest in costly production facilities and expertise.
Their expertise enables targeting a broader range of antigens than possible in vivo, including poorly immunoreactive and toxic compounds, with products available on a range of scales (milligrams to kilograms). As a rapid alternative to producing full-length monoclonal antibodies, Fab fragments can be generated in just three months and greatly enhance the specificity and sensitivity of IVD assays in solid-phase applications. Manufacturing presents a cost-effective and flexible monoclonal antibody outsourcing option for IVD manufacturers.
Their products are used to develop diagnostic tests for bone metabolism, cardiovascular, diabetes & metabolism, hormones, infectious diseases, inflammation, serology, thyroid, and tumour diseases